Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This post-marketing surveillance (PMS) study is designed to investigate the efficacy and safety of azathioprine tablets in Japanese subjects whom liver transplantation is performed.

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Azathioprine

Criteria

Inclusion Criteria:

• Subjects who undergo liver transplantation and azathioprine tablet was administered

Exclusion Criteria:

As this is PMS study, there are no exclusion criteria but contraindications are as follows.

• Subjects with hypersensitivity to the ingredients of azathioprine tablet

• Subjects who is pregnant or might be pregnant

• Subjects whose white count is lower than 3000/cubic millimeter